Skip to main content
. 2021 Jan 15;2021(1):CD012768. doi: 10.1002/14651858.CD012768.pub3

Heemskerk 2018.

Study characteristics
Patient Sampling Cross‐sectional, consecutive, prospective
Patient characteristics and setting Presenting signs and symptoms: patients who were offered lumbar puncture as a part of routine care for suspected brain infection
Age: ≥ 18 years; median 37 years (IQR 28 to 50)
Sex, female: 43%
Children: no
HIV infection: 31%
Clinical setting: multicentre, hospital‐based (both referral and local)
Past history of TB:
Participants on anti‐TB treatment:
Number of specimens evaluated: 610
Laboratory level: central in South Africa
Country: South Africa, Vietnam, Indonesia
World Bank Income Classification: middle
High TB burden: South Africa yes; Vietnam yes; Indonesia yes
High TB/HIV burden: South Africa yes; Vietnam no; Indonesia yes
High MDR‐TB burden: South Africa yes; Vietnam yes; Indonesia yes
Index tests Xpert MTB/RIF
WHO SOP or manufacturer's protocol followed: no (as performed in Nhu 2014)
Target condition and reference standard(s) TB meningitis
CRS: clinical TB meningitis, diagnosis (definite, probable and possible TB meningitis); MGIT (MODS Indonesia)
Speciation yes
Decontamination: no
Flow and timing  
Comparative  
Notes  
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
Could the selection of patients have introduced bias?   Low risk  
Are there concerns that the included patients and setting do not match the review question?     Low concern
DOMAIN 2: Index Test (Xpert MTB/RIF)
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Yes    
Could the conduct or interpretation of the index test have introduced bias?   Low risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     High
DOMAIN 2: Index Test (Xpert Ultra)
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Yes    
For rifampicin resistance testing, were the reference standard results interpreted without knowledge of the results of the index test?      
Could the reference standard, its conduct, or its interpretation have introduced bias?   Low risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Could the patient flow have introduced bias?   Low risk